Sort
50,496 grants matching “lung cancer”
Early Life Adversity and Adulthood Health: The Role of Pubertal Development
$736,418Maria E. Bleil · University Of Washington · R01 · FY2019 · HL
Novel Pathogen Associated Cancers (PQ12)
$736,412Denise A. Galloway · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Case-Control Study of Pancreas Cancer Etiologic Factors
$736,394Harvey A Risch · Yale University · R01 · FY2006 · CA
TELEhealth Shared decision-making COaching for lung cancer screening in Primary care (TELESCOPE)
$736,380Anita Y Kinney · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · HL
Tissue Array Research Program
$736,349Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
A Sparse-readout Quantitative PET scanner for breast cancer therapy optimization
$736,315William Coulis Jason Hunter · Pet/X, Llc · R42 · FY2021 · CA
Probing cytosolic nucleic acid sensing pathways in cancer
$736,310Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Antigen-specific radiosensitization
$736,168Daniel Higginson · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Advancing Communication Science to Reduce Disparities in Young Adult Cigar Use
$736,139Adam O Goldstein · Univ Of North Carolina Chapel Hill · U54 · FY2025 · DA
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDS
$736,081Igor I Slukvin · University Of Wisconsin-Madison · R24 · FY2019 · OD
PLCO Trial Etiologic and Early Marker Study
$736,077Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Endothelial Cell-Targeted Amatoxin Conjugates for Effective Therapy of Breast Cancer
$735,974Bogdan Olenyuk · Proteogenomics Research Instit/Sys/ Med · R01 · FY2020 · CA
Harnessing Platelet-Endothelial Interactions for Exosome Delivery
$735,942Ke Cheng · Columbia Univ New York Morningside · R01 · FY2024 · HL
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
$735,826William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Rescuing Nucleic Acids from Formalin Damage in Cancer Specimens
$735,637Lucian Orbai · Cell Data Sciences, Inc. · R44 · FY2017 · CA
Targeting cell state transitions driving resistance to KRAS inhibitors in lung cancer
$735,635Kwok Kin Wong · New York University School Of Medicine · R01 · FY2024 · CA
Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients
$735,600Wendy Cozen · University Of Southern California · R01 · FY2016 · CA
Consequences of retrotransposition on genome integrity
$735,574Kathleen H Burns · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Antibody Therapy of Cancer
$735,484Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$735,451Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
$735,428Song Yao · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Rational antibody therapy for IPF
$735,251Andrew R Mendelsohn · Panorama Research, Inc. · R44 · FY2017 · HL
The Role of Wnt Genes in Vertebrate Development and Cancer
$735,207Terence Yamaguchi · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Dissecting the impact of tumor-intrinsic chromosomal instability on the cancer ecosystem
$735,170Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Sequencing Familial Lung Cancer
$735,139Christopher I. Amos · Baylor College Of Medicine · U01 · FY2020 · CA